Clinical Subject Page
Cardiogenic Shock
Cardiogenic shock is a life-threatening state of inadequate tissue perfusion caused by severe cardiac pump failure, resulting in reduced cardiac output despite adequate intravascular volume.
Also called
Cardiac Shock
ICD-10
R57.0
Specialty
Cardiology
Onset
Acute
Reviewed
June 2026
On This Page
-
OverviewOverview
-
Etiology & Risk FactorsEtiology & Risk Factors
-
PathophysiologyPathophysiology
-
Clinical PresentationClinical Presentation
-
History TakingHistory Taking
-
Physical ExaminationPhysical Examination
-
InvestigationsInvestigations
-
DiagnosisDiagnosis
-
ManagementManagement
-
ComplicationsComplications
-
PrognosisPrognosis
-
Key Points / Clinical PearlsKey Points / Clinical Pearls
Overview
Cardiogenic shock is a form of shock caused by failure of the heart to pump effectively, resulting in decreased cardiac output (CO), hypotension, and inadequate tissue perfusion. Pulmonary congestion and edema commonly occur because of increased pulmonary hydrostatic pressure.
Teaching point
Acute myocardial infarction is the most common cause of cardiogenic shock, and early revascularization significantly improves survival.
Etiology & Risk Factors
The most common cause is myocardial infarction (MI).
Other causes include:
- Arrhythmias
- Heart failure
- Cardiomyopathy
- Myocarditis
- Mechanical complications:
- Ventricular septal defect
- Ventricular rupture
- Severe valvular disease:
- Severe aortic regurgitation
- Severe mitral regurgitation
- Blunt cardiac trauma
- Certain drugs (e.g., beta blockers, calcium channel blockers)
Pathophysiology
Underlying cardiac dysfunction leads to:
- ↓ Cardiac contractility and/or ↓ stroke volume
- ↓ Cardiac output
Systemic effects:
- ↓ Blood pressure
- Catecholamine release → vasoconstriction and increased myocardial oxygen demand
- Activation of the renin-angiotensin-aldosterone system → further vasoconstriction and sodium/water retention
- Blood shunting to vital organs → inadequate peripheral organ perfusion
Pulmonary effects:
- Increased pulmonary hydrostatic pressure
- Pulmonary edema
Clinical Presentation
Symptoms
- Severe chest pain (if MI)
- Dyspnea
- Fatigue
- Dizziness
- Altered mental status
- Oliguria
Signs
- Hypotension
- Cold, clammy skin
- Tachycardia
- Pulmonary edema
- Cyanosis
- Peripheral vasoconstriction
Important Note
Persistent hypotension with signs of end-organ hypoperfusion following acute MI strongly suggests cardiogenic shock.
History Taking
Key Questions
- Sudden chest pain?
- Shortness of breath?
- Previous heart attack?
- History of heart failure?
- Palpitations?
- Syncope?
- Recent myocarditis?
- Known valvular disease?
Red Flags
- Persistent hypotension
- Altered consciousness
- Chest pain
- Pulmonary edema
- Reduced urine output
Physical Examination
General
- Pale, cold, clammy patient
- Distressed appearance
Vital Signs
- Hypotension (SBP <90 mmHg)
- Tachycardia
- Tachypnea
- Low oxygen saturation
Cardiovascular
- Weak, thready pulse
- Elevated jugular venous pressure
- S3 gallop
- New systolic murmur (mechanical complications)
- Cool extremities
Respiratory
- Bibasal crackles
- Pulmonary edema
Peripheral
- Delayed capillary refill
- Cyanosis
- Reduced urine output
Investigations
Laboratory
- CBC
- Electrolytes
- Renal & liver function
- Troponin
- BNP/NT-proBNP
- Arterial blood gas
- Serum lactate
- Coagulation profile
ECG
- Acute MI changes
- Arrhythmias
Imaging
- Echocardiography (first-line)
- Chest X-ray
- Coronary angiography (if ACS suspected)
Hemodynamic Monitoring
- Arterial line
- Central venous access
- Pulmonary artery catheter (selected patients)
Diagnosis
Diagnosis is based on:
- Clinical evidence of shock
- SBP <90 mmHg (or need for vasopressors)
- Signs of end-organ hypoperfusion
- Elevated lactate
- Echocardiographic evidence of severe cardiac dysfunction
- Identification of the underlying cardiac cause
Management
Initial Stabilization
- Airway and oxygenation
- Continuous cardiac monitoring
- IV access
- Treat reversible causes
Medications
- Vasopressors (Norepinephrine first-line)
- Inotropes (Dobutamine)
- Diuretics (if pulmonary congestion and adequate BP)
- Antiplatelet and anticoagulation (ACS)
- Vasodilators only if hemodynamically stable
Definitive Treatment
- Urgent PCI or CABG for acute MI
- Surgical repair of mechanical complications
- Treat arrhythmias
- Valve intervention if indicated
Mechanical Circulatory Support
- Intra-aortic balloon pump (selected patients)
- Impella
- VA-ECMO
Complications
- Multi-organ failure
- Acute kidney injury
- Pulmonary edema
- Life-threatening arrhythmias
- Cardiac arrest
- Death
Prognosis
- Cardiogenic shock has a high mortality despite treatment.
- Early diagnosis and rapid revascularization significantly improve survival.
- Prognosis depends on the underlying cause and response to therapy.
Key Points / Clinical Pearls
- Acute myocardial infarction is the most common cause.
- Hypotension with end-organ hypoperfusion defines cardiogenic shock.
- Echocardiography is the first-line imaging modality.
- Urgent coronary revascularization is lifesaving in MI-related shock.
- Norepinephrine is the preferred initial vasopressor.
- Early recognition and multidisciplinary management improve outcomes.
- Kosaraju A, Pendela VS, Hai O. National Center for Biotechnology Information (NIH). Cardiogenic Shock, StatPearls.
- Naidu SS, Baran DA, Jentzer JC, et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies. J Am Coll Cardiol. 2022;79:933-946. doi: 10.1016/j.jacc.2022.01.018.
- National Center for Biotechnology Information (NIH). Shock, StatPearls.
- National Heart, Lung, and Blood Institute (NIH). Cardiogenic Shock: Health Topic.
- National Center for Biotechnology Information (NIH). Shock Resuscitation, StatPearls.